State Street XLV vs. iShares IXJ: Here's How These Healthcare ETFs Stack Up for Investors
XLV's 0.08% expense ratio and 22.7% 1-year return outpace IXJ's global reach, but international diversification comes at a cost.
We haven't written up this one. Motley Fool has the full story — the link below goes straight to it.